The Recall Desk

Archive

February 2023 recalls

503 recalls were announced in February 2023.

What the numbers show

Critical
6
Severe
69
High
395
Moderate
32
Low
1

Of the 503 recalls this month scored against our rubric, 1% are Critical, 14% are Severe.

Which agencies issued them

501–503 of 503

  • ModerateFDA (Drugs)·D-0174-2023·2023-02-01

    Clobetasol Propionate Cream recalled due to subpotent drug

    Lupin Pharmaceuticals is recalling Clobetasol Propionate Cream 0.05% nationwide because stability testing revealed insufficient active ingredient in the affected lot.

    Product
    CLOBETASOL PROPIONATE — CLOBETASOL PROPIONATE (CLOBETASOL PROPIONATE)
    Category
    Drug
    Distribution
    Distributed nationwide
  • ModerateFDA (Drugs)·D-0172-2023·2023-02-01

    FDA Recalls Fentanyl Injection Solution for Underfilled Cassettes

    OurPharma LLC is recalling 768 cassettes of FentaNYL Citrate injection solution due to underfilled units. The affected product was distributed in Illinois and Missouri.

    Product
    FentaNYL Citrate 2.5mg/50mL (50mcg/mL) Injection Solution, Preservative-Free IV Injection 50mL Cassette, Rx Only, OurPharma, LLC, 2512 S. City Lake Rd., Fayetteville, AR 72701, NDC 73013-1001-01.
    Category
    Drug
    Distribution
    2 states
  • ModerateFDA (Devices)·Z-1016-2023·2023-02-01

    Intraoperative PTH Test Kits Recalled Due to High Result Variability

    Future Diagnostics recalled STAT-IntraOperative-Intact-PTH immunoassay kits due to high coefficient of variability in test results. 342 kits were distributed worldwide.

    Product
    Future Diagnostics STAT-IntraOperative-Intact-PTH (STAT-IO-I-PTH) Immunoassay kit REF 4K-IPT-00. in vitro diagnostic.
    Category
    Medical Device
    Distribution
    7 states

Looking for a different month? Back to 2023.